|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
|
EP1305308B1
(en)
|
2000-07-26 |
2006-12-20 |
Smithkline Beecham Plc |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
|
|
WO2002024684A1
(en)
*
|
2000-09-21 |
2002-03-28 |
Smithkline Beecham P.L.C. |
Quinoline derivatives as antibacterials
|
|
GB0031086D0
(en)
*
|
2000-12-20 |
2001-01-31 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0101577D0
(en)
|
2001-01-22 |
2001-03-07 |
Smithkline Beecham Plc |
Compounds
|
|
GB0112834D0
(en)
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0112836D0
(en)
*
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
US6632810B2
(en)
*
|
2001-06-29 |
2003-10-14 |
Kowa Co., Ltd. |
Cyclic diamine compound with condensed-ring groups
|
|
ATE449090T1
(de)
*
|
2001-07-02 |
2009-12-15 |
High Point Pharmaceuticals Llc |
Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
|
|
GB0118238D0
(en)
*
|
2001-07-26 |
2001-09-19 |
Smithkline Beecham Plc |
Medicaments
|
|
US7312212B2
(en)
|
2002-01-29 |
2007-12-25 |
Glaxo Group Limited |
Aminopiperidine derivatives
|
|
EP1470131A2
(en)
*
|
2002-01-29 |
2004-10-27 |
Glaxo Group Limited |
Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
|
|
CN1172919C
(zh)
*
|
2002-06-03 |
2004-10-27 |
上海医药工业研究院 |
芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用
|
|
TW200406413A
(en)
|
2002-06-26 |
2004-05-01 |
Glaxo Group Ltd |
Compounds
|
|
AR040336A1
(es)
|
2002-06-26 |
2005-03-30 |
Glaxo Group Ltd |
Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
|
|
GB0217294D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicaments
|
|
EP1551829B1
(de)
*
|
2002-10-10 |
2010-04-07 |
Morphochem Aktiengesellschaft Für Kombinatorische Chemie |
Neue verbindungen mit antibakterieller aktivität
|
|
EP1560488B1
(en)
|
2002-11-05 |
2010-09-01 |
Glaxo Group Limited |
Antibacterial agents
|
|
US7232832B2
(en)
|
2002-11-05 |
2007-06-19 |
Smithkline Beecham Corporation |
Antibacterial agents
|
|
WO2004050036A2
(en)
|
2002-12-04 |
2004-06-17 |
Glaxo Group Limited |
Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
|
|
TW200507841A
(en)
*
|
2003-03-27 |
2005-03-01 |
Glaxo Group Ltd |
Antibacterial agents
|
|
AU2004261283B2
(en)
*
|
2003-07-31 |
2008-05-01 |
Irm, Llc |
Bicyclic compounds and compositions as PDF inhibitors
|
|
JP2008509222A
(ja)
*
|
2004-08-09 |
2008-03-27 |
グラクソ グループ リミテッド |
抗菌剤
|
|
US7906645B2
(en)
*
|
2004-12-24 |
2011-03-15 |
Astrazeneca Ab |
Heterocyclic compounds as ccr2b antagonists
|
|
GB0428327D0
(en)
*
|
2004-12-24 |
2005-02-02 |
Astrazeneca Ab |
Method
|
|
NZ590148A
(en)
|
2004-12-30 |
2012-04-27 |
Janssen Pharmaceutica Nv |
Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
|
|
JP2008528598A
(ja)
|
2005-01-25 |
2008-07-31 |
グラクソ グループ リミテッド |
抗菌剤
|
|
EP1845995A4
(en)
|
2005-01-25 |
2010-03-03 |
Glaxo Group Ltd |
ANTIBACTERIAL AGENTS
|
|
US7511035B2
(en)
|
2005-01-25 |
2009-03-31 |
Glaxo Group Limited |
Antibacterial agents
|
|
JP2008528586A
(ja)
|
2005-01-25 |
2008-07-31 |
グラクソ グループ リミテッド |
抗菌剤
|
|
WO2006081182A2
(en)
|
2005-01-25 |
2006-08-03 |
Glaxo Group Limited |
Antibacterial agents
|
|
JP5023054B2
(ja)
|
2005-03-31 |
2012-09-12 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗バクテリア剤としての二環式ピラゾール化合物
|
|
JP4902247B2
(ja)
*
|
2005-04-08 |
2012-03-21 |
富山化学工業株式会社 |
２−（１−ベンゾチオフェン−５−イル）エタノールの新規製造法およびその中間体
|
|
MY150958A
(en)
|
2005-06-16 |
2014-03-31 |
Astrazeneca Ab |
Compounds for the treatment of multi-drug resistant bacterial infections
|
|
EP1900732A4
(en)
|
2005-06-24 |
2009-11-18 |
Toyama Chemical Co Ltd |
NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
|
|
GB0525957D0
(en)
*
|
2005-12-21 |
2006-02-01 |
Astrazeneca Ab |
Methods
|
|
ATE536351T1
(de)
|
2006-01-26 |
2011-12-15 |
Actelion Pharmaceuticals Ltd |
Tetrahydropyran-antibiotika
|
|
WO2007098214A1
(en)
*
|
2006-02-21 |
2007-08-30 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
US20070287707A1
(en)
*
|
2006-02-28 |
2007-12-13 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
|
WO2007103554A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
EP2001887B1
(en)
|
2006-04-06 |
2010-09-15 |
Glaxo Group Limited |
Pyrrolo-quinoxalinone derivatives as antibacterials
|
|
WO2007118130A2
(en)
|
2006-04-06 |
2007-10-18 |
Glaxo Group Limited |
Antibacterial agents
|
|
AU2007268749B2
(en)
|
2006-05-26 |
2012-07-26 |
Taisho Pharmaceutical Co., Ltd. |
Novel heterocyclic compound or salt thereof and intermediate thereof
|
|
GB0613208D0
(en)
|
2006-07-03 |
2006-08-09 |
Glaxo Group Ltd |
Compounds
|
|
EP1992628A1
(en)
|
2007-05-18 |
2008-11-19 |
Glaxo Group Limited |
Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
|
|
AU2008240764C1
(en)
*
|
2007-04-20 |
2011-10-20 |
Glaxo Group Limited |
Tricyclic nitrogen containing compounds as antibacterial agents
|
|
CN101874032B
(zh)
|
2007-11-26 |
2013-02-06 |
富山化学工业株式会社 |
二氮杂萘衍生物一水合物及其制备方法
|
|
EP2080761A1
(en)
|
2008-01-18 |
2009-07-22 |
Glaxo Group Limited |
Compounds
|
|
EP2352734A1
(en)
|
2008-10-17 |
2011-08-10 |
Glaxo Group Limited |
Tricyclic nitrogen compounds used as antibacterials
|
|
US8318940B2
(en)
|
2009-01-15 |
2012-11-27 |
Glaxo Group Limited |
Naphthyridin-2 (1 H)-one compounds useful as antibacterials
|
|
US8673920B2
(en)
|
2009-05-06 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
AU2010291834A1
(en)
*
|
2009-09-04 |
2012-03-15 |
Zalicus Pharmaceuticals Ltd. |
Substituted heterocyclic derivatives for the treatment of pain and epilepsy
|
|
EP2632465B1
(en)
|
2010-10-27 |
2015-12-30 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2632464B1
(en)
|
2010-10-29 |
2015-04-29 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
GB201106817D0
(en)
|
2011-04-21 |
2011-06-01 |
Astex Therapeutics Ltd |
New compound
|
|
MX2014001946A
(es)
|
2011-08-19 |
2014-03-27 |
Merck Sharp & Dohme |
Inhibidores del canal de potasio medularmente externo renal.
|
|
WO2013039802A1
(en)
|
2011-09-16 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2013062900A1
(en)
|
2011-10-25 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2013062892A1
(en)
|
2011-10-25 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2773351B1
(en)
|
2011-10-31 |
2017-08-23 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2773206B1
(en)
|
2011-10-31 |
2018-02-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2013066714A1
(en)
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2790511B1
(en)
|
2011-12-16 |
2016-09-14 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
AR089929A1
(es)
|
2012-02-10 |
2014-10-01 |
Actelion Pharmaceuticals Ltd |
Proceso para manufacturar un derivado de naftiridina
|
|
AR092031A1
(es)
|
2012-07-26 |
2015-03-18 |
Merck Sharp & Dohme |
Inhibidores del canal de potasio medular externo renal
|
|
GB201218850D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
GB201218862D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
GB201218864D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
US9980973B2
(en)
|
2012-10-19 |
2018-05-29 |
Astex Therapeutics Limited |
Bicyclic heterocycle compounds and their uses in therapy
|
|
EP2925322B1
(en)
|
2012-11-29 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9573961B2
(en)
|
2012-12-19 |
2017-02-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9604998B2
(en)
|
2013-02-18 |
2017-03-28 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2961403A4
(en)
|
2013-03-01 |
2016-11-30 |
Zalicus Pharmaceuticals Ltd |
HETEROCYCLIC INHIBITORS OF SODIUM CHANNEL
|
|
WO2014150132A1
(en)
|
2013-03-15 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2015017305A1
(en)
|
2013-07-31 |
2015-02-05 |
Merck Sharp & Dohme Corp |
Inhibitors of the renal outer medullary potassium channel
|
|
BR122022015241B1
(pt)
|
2013-12-20 |
2023-09-26 |
Astex Therapeutics Limited |
Compostos heterocíclicos bicíclicos intermediários para a preparação de um composto de fórmula (i)
|
|
EP3110799A4
(en)
*
|
2014-02-27 |
2017-10-11 |
Epirus Biopharmaceuticals, Inc. |
Heterocyclic inhibitors of the sodium channel
|
|
US10702521B2
(en)
|
2014-08-22 |
2020-07-07 |
Glaxosmithkline Intellectual Property Development Limited |
Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
|
|
WO2016127358A1
(en)
|
2015-02-12 |
2016-08-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of renal outer medullary potassium channel
|
|
TW201722965A
(zh)
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|
|
KR20220087497A
(ko)
|
2019-10-18 |
2022-06-24 |
더 리전츠 오브 더 유니버시티 오브 캘리포니아 |
병원성 혈관을 표적화하기 위한 화합물 및 방법
|
|
US12590298B2
(en)
|
2019-10-18 |
2026-03-31 |
The Regents Of The University Of California |
Ex vivo tumor angiogenesis model
|